News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,693 Results
Type
Article (42555)
Company Profile (294)
Press Release (676844)
Multimedia
Podcasts (81)
Webinars (12)
Section
Business (210479)
Career Advice (2092)
Deals (36636)
Drug Delivery (107)
Drug Development (83069)
Employer Resources (175)
FDA (16587)
Job Trends (15417)
News (356122)
Policy (33932)
Tag
Academia (2599)
Accelerated approval (5)
Adcomms (21)
Allergies (92)
Alliances (51452)
ALS (99)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (140)
Approvals (16584)
Artificial intelligence (280)
Autoimmune disease (24)
Automation (17)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (188)
Bladder cancer (79)
Brain cancer (29)
Breast cancer (293)
Cancer (2355)
Cardiovascular disease (188)
Career advice (1753)
Career pathing (31)
CAR-T (157)
Cell therapy (443)
Cervical cancer (20)
Clinical research (67647)
Collaboration (880)
Company closure (2)
Compensation (572)
Complete response letters (25)
COVID-19 (2663)
CRISPR (47)
C-suite (258)
Cystic fibrosis (106)
Data (2338)
Decentralized trials (2)
Denatured (29)
Depression (47)
Diabetes (279)
Diagnostics (6465)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (115)
Drug shortages (28)
Duchenne muscular dystrophy (97)
Earnings (88722)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (115534)
Executive appointments (758)
FDA (17986)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (777)
Gene editing (116)
Generative AI (22)
Gene therapy (330)
GLP-1 (760)
Government (4552)
Grass and pollen (5)
Guidances (158)
Healthcare (19004)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (134)
Indications (30)
Infectious disease (2809)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (100)
Interviews (323)
IPO (16803)
IRA (47)
Job creations (4060)
Job search strategy (1492)
Kidney cancer (10)
Labor market (43)
Layoffs (499)
Leadership (18)
Legal (8380)
Liver cancer (77)
Lung cancer (327)
Lymphoma (159)
Machine learning (9)
Management (59)
Manufacturing (340)
MASH (79)
Medical device (13478)
Medtech (13483)
Mergers & acquisitions (20399)
Metabolic disorders (731)
Multiple sclerosis (83)
NASH (17)
Neurodegenerative disease (99)
Neuropsychiatric disorders (29)
Neuroscience (1980)
NextGen: Class of 2025 (6637)
Non-profit (4528)
Now hiring (40)
Obesity (386)
Opinion (230)
Ovarian cancer (82)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (153)
Partnered (22)
Patents (248)
Patient recruitment (116)
Peanut (49)
People (59328)
Pharmaceutical (91)
Pharmacy benefit managers (20)
Phase I (20984)
Phase II (29767)
Phase III (22300)
Pipeline (1381)
Policy (160)
Postmarket research (2654)
Preclinical (8942)
Press Release (68)
Prostate cancer (109)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (404)
Real estate (6258)
Recruiting (67)
Regulatory (23192)
Reports (47)
Research institute (2369)
Resumes & cover letters (358)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (80)
Series A (134)
Series B (88)
Service/supplier (12)
Sickle cell disease (55)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3731)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (53)
The Weekly (50)
Vaccines (720)
Venture capitalists (42)
Weight loss (256)
Women's health (36)
Worklife (16)
Date
Today (143)
Last 7 days (971)
Last 30 days (3112)
Last 365 days (32990)
2025 (12004)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54792)
2019 (47405)
2018 (35773)
2017 (33138)
2016 (32663)
2015 (38616)
2014 (32520)
2013 (27631)
2012 (29730)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (40773)
Australia (6529)
California (6436)
Canada (2077)
China (556)
Colorado (275)
Connecticut (281)
Delaware (161)
Europe (87116)
Florida (958)
Georgia (213)
Idaho (57)
Illinois (560)
India (26)
Indiana (330)
Iowa (11)
Japan (175)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (928)
Massachusetts (4822)
Michigan (227)
Minnesota (406)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1806)
New Mexico (29)
New York (1812)
North Carolina (1006)
North Dakota (8)
Northern California (2832)
Ohio (210)
Oklahoma (14)
Oregon (39)
Pennsylvania (1435)
Puerto Rico (13)
Rhode Island (33)
South America (1163)
South Carolina (25)
South Dakota (1)
Southern California (2417)
Tennessee (105)
Texas (960)
United States (24214)
Utah (190)
Virginia (160)
Washington D.C. (64)
Washington State (572)
West Virginia (3)
Wisconsin (59)
719,693 Results for "xenon pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 2, 2025
May 5, 2025
·
2 min read
Press Releases
Xenon to Report Q1 2025 Financial Results on May 12, 2025
May 6, 2025
·
1 min read
Press Releases
Xenon to Present at Stifel 2025 Virtual CNS Forum
March 13, 2025
·
1 min read
Press Releases
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
April 7, 2025
·
5 min read
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
Xenon Pharmaceuticals Inc. announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV.
May 8, 2024
·
1 min read
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global Healthcare Conference taking place June 10-13, 2024 in Miami, FL.
June 5, 2024
·
1 min read
Business
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 9, 2024
·
12 min read
Press Releases
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
February 25, 2025
·
1 min read
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY.
May 7, 2024
·
1 min read
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Xenon Pharmaceuticals Inc. today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024.
April 10, 2024
·
1 min read
1 of 71,970
Next
